Medical Launch Advisor – France (Phase IV)

Alfasigma is a privately held global healthcare company with a strong focus on GI health, expanding its presence in France. We seek a Medical Advisor on a fixed-term assignment (Sept 2026–May 2027) reporting to the Medical Director to lead medical launch activities for a new indication in France.

You will drive Phase IV evidence, engage external experts, develop medical content, and ensure scientific readiness across cross-functional teams while maintaining the highest standards of ethics and